Fluidigm Corporation logo
Fluidigm Corporation FLDM

Fluidigm Corporation Market Cap 2011-2025 | FLDM

As of December 15, 2025 Fluidigm Corporation has a market cap of $ 308 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Fluidigm Corporation

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
481 M 262 M 340 M 216 M 175 M 193 M 1.07 B 1.14 B 361 M 264 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.14 B 175 M 450 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Diagnostics research industry

Issuer Market Cap Price % 24h Market Cap Country
Centogene N.V. Centogene N.V.
CNTG
221 M - -6.23 % $ 30.6 M germanyGermany
Akumin Akumin
AKU
75.1 M - -17.87 % $ 25.9 M canadaCanada
Brainsway Ltd. Brainsway Ltd.
BWAY
240 M $ 16.82 -0.18 % $ 99.4 M israelIsrael
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
2.95 B $ 16.38 3.97 % $ 170 M chinaChina
Accelerate Diagnostics Accelerate Diagnostics
AXDX
40.3 M - -61.36 % $ 2.46 M usaUSA
Biocept Biocept
BIOC
5.93 M - -13.05 % $ 7.29 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
3.55 M $ 1.6 -1.23 % $ 2.03 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
421 M - - $ 562 M britainBritain
Castle Biosciences Castle Biosciences
CSTL
709 M $ 39.39 1.97 % $ 1.09 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
12.6 M - 0.22 % $ 16.8 M usaUSA
Danaher Corporation Danaher Corporation
DHR
152 B $ 228.73 0.98 % $ 167 B usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
43.4 M $ 11.97 0.67 % $ 340 M israelIsrael
DexCom DexCom
DXCM
48.8 B $ 67.19 0.34 % $ 25.9 B usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
9.32 B $ 101.46 -0.04 % $ 18.8 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
467 M $ 27.23 0.31 % $ 823 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
243 M - - $ 399 M chinaChina
Genetic Technologies Limited Genetic Technologies Limited
GENE
9.22 B - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
1.54 B - 0.12 % $ 80.1 M chinaChina
DermTech DermTech
DMTK
42.4 M - -11.32 % $ 2.94 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
7.87 B - - $ 10.7 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
521 M $ 20.72 0.78 % $ 1.11 B usaUSA
Celcuity Celcuity
CELC
399 M $ 105.02 -0.22 % $ 4.14 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
57.5 K - -8.98 % $ 14.8 K usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
70.8 K $ 3.41 -4.75 % $ 109 K usaUSA
Co-Diagnostics Co-Diagnostics
CODX
34.9 M $ 0.33 -3.34 % $ 9.68 M usaUSA
Quidel Corporation Quidel Corporation
QDEL
10.6 B $ 28.72 -0.28 % $ 1.21 B usaUSA
Guardant Health Guardant Health
GH
5.84 B $ 103.82 1.72 % $ 12.7 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
35.7 B $ 223.38 0.52 % $ 40.5 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
45.4 M - -6.19 % $ 10.5 M usaUSA
Heska Corporation Heska Corporation
HSKA
844 M - - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
2.99 M - -20.0 % $ 1.06 M usaUSA
Illumina Illumina
ILMN
16.4 B $ 135.16 0.22 % $ 21.5 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
8.54 B $ 197.73 2.46 % $ 10.2 B usaUSA
Quotient Limited Quotient Limited
QTNT
183 M - -11.32 % $ 1.1 M schweizSchweiz
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
19.1 B $ 184.0 0.82 % $ 20.4 B usaUSA
Biodesix Biodesix
BDSX
92.1 M $ 7.85 - $ 1.02 B usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
21.1 B $ 264.75 0.22 % $ 22.2 B usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
16.6 B $ 187.27 0.37 % $ 15.4 B irlandaIrlanda
IDEXX Laboratories IDEXX Laboratories
IDXX
37.7 B $ 707.12 0.41 % $ 58.3 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
6.47 B $ 66.85 0.35 % $ 4.63 B usaUSA
Agilent Technologies Agilent Technologies
A
42 B $ 140.96 0.93 % $ 42.9 B usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
29.9 B $ 1 405.6 0.84 % $ 29.8 B schweizSchweiz
Myriad Genetics Myriad Genetics
MYGN
973 M $ 7.22 0.14 % $ 654 M usaUSA
Biomerica Biomerica
BMRA
7.19 M $ 2.53 -1.94 % $ 5.81 M usaUSA
Bioventus Bioventus
BVS
351 M $ 7.64 1.13 % $ 479 M usaUSA
NeoGenomics NeoGenomics
NEO
1.53 B $ 11.87 0.16 % $ 1.5 B usaUSA
Neogen Corporation Neogen Corporation
NEOG
1.02 B $ 6.82 -0.66 % $ 1.48 B usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
4.33 M - - $ 9.42 M israelIsrael
Motus GI Holdings Motus GI Holdings
MOTS
990 K - -34.28 % $ 263 K israelIsrael